BioCorRx (BICX) Invested Capital (2021 - 2026)

BioCorRx has reported Invested Capital for 8 years, with the latest figure at $4.9 million in Q1 2026.

• Quarterly Invested Capital changed N/A year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (down 22.86% YoY) and the FY2025 annual result came in at $4.8 million, up 11.09% from the prior year.
• Invested Capital climbed to $4.9 million in Q1 2026 per BICX's latest filing, from $4.8 million in the prior quarter.
• Over five years, Invested Capital peaked at $4.9 million in Q1 2026 and troughed at $3.0 million in Q1 2022.
• A 5-year average of $3.9 million and a median of $3.9 million in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2025: Invested Capital climbed 19.05% in 2022, then increased 11.09% in 2025.
• Over 5 years, Invested Capital stood at $3.3 million in 2022, then climbed by 14.27% to $3.8 million in 2023, then climbed by 12.57% to $4.3 million in 2024, then climbed by 11.09% to $4.8 million in 2025, then advanced by 2.41% to $4.9 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $4.9 million, $4.8 million, and $4.3 million for Q1 2026, Q4 2025, and Q4 2024 respectively.